Historical data shows that a consistent $500 monthly investment into Turn Therapeutics Inc. (TTRX) starting in 2020 would have turned a total investment of $14K into $14K today. This represents a total return of 0.9% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Turn Therapeutics Inc. does not currently pay a notable dividend. For growth-focused stocks like TTRX, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $14K without the need for dividend reinvestment.
TTRX vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,TTRX underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $15K, compared to TTRX's $14K.